HLA Typing Market by Size, Share, Forecasts, & Trends Analysis

[Redding, California - Feb 19, 2024] - Meticulous Research®, a renowned global market research entity, is pleased to announce the release of its latest research report, "HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Global Forecast to 2029."

Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5311

According to Meticulous Research®, the HLA typing market is poised for significant growth, with a projected CAGR of 5.6% during the forecast period, aiming to reach a valuation of $1.9 billion by 2029. This optimistic outlook is underpinned by the rising number of organ transplants and noteworthy technological advancements in HLA typing. The report also highlights the pivotal role of growing awareness about organ donations in creating lucrative opportunities for the global HLA typing market. However, challenges such as the high costs associated with molecular techniques and the persistent shortage of organs for transplantation pose obstacles to market expansion.

Future Outlook of HLA Typing Market

The global HLA typing market is comprehensively segmented by Product (Instruments, Consumables, Software & Services), Technology (Molecular technologies [PCR-based Molecular Techniques {Sequence-specific Primers, Sequence-specific Oligonucleotide, and Other PCR-based Molecular Techniques}, Sequencing-based Molecular Technologies {Sanger Sequencing, Next Generation Sequencing, Pyrosequencing}, DNA Microarray], Non-molecular Technologies), Application (Diagnostics [Donor Recipient Cross-matching, Transfusion Therapy, and Other Diagnostics Applications], Research), End User (Diagnostics Labs, Hospital & Transplant Centers, Academic & Research Institutes), and Geography. The report meticulously evaluates industry competitors and conducts in-depth analyses of regional and country markets.

Key Findings:

Product Segment: In 2022, the consumables segment is anticipated to dominate the HLA typing market, driven by the growing applications of molecular assay techniques and the increasing adoption of molecular diagnostic techniques in research studies.

Speak to Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5311

Technology Segment: The molecular technologies segment is projected to hold the largest market share in 2022, owing to advancements in molecular assays and the inherent advantages of molecular techniques over non-molecular ones.

Application Segment: Diagnostics is expected to be the leading application segment in 2022, driven by the increasing use of HLA typing in disease diagnosis, pathogenesis, and the rising incidences of infectious and chronic diseases globally.

End User Segment: Diagnostic laboratories are forecasted to contribute the largest share in 2022, as they conduct the maximum number of HLA typing procedures, with hospitals often outsourcing their diagnostic capabilities.

Geographical Analysis: North America is anticipated to dominate the HLA typing market in 2022, followed by Europe and Asia-Pacific. The dominance of North America is attributed to the high prevalence of cancer and autoimmune diseases, a significant number of organ transplants, and government funding for HLA and killer cell immunoglobulin-like receptors (KIR) for immune-mediated diseases.

Quick Buy: https://www.meticulousresearch.com/Checkout/76618224

Key Players in the HLA Typing Market:

Prominent players in the global HLA typing market include Thermo Fisher Scientific Inc., Bio-rad Laboratories, Qiagen N.V., Genome Diagnostics B.V. (GenDx), Illumina, Inc., CareDx, Immucor Inc., TBG Diagnostics Limited, BAG Diagnostic GmbH, Omixon Inc., Luminex Corporation, inno-train Diagnostik GmbH, Pacific Biosciences of California, Inc., and Fujirebio Holdings, Inc.

Office No-202, 203,204,205,206 2nd Floor, Pushpak Business Hub, Wakad, , India.

About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

This release was published on openPR.